A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2028

Conditions
Head and Neck Squamous Cell Carcinoma
Trial Locations (23)

10029

RECRUITING

Mount Sinai Hospital, New York

17403

RECRUITING

Cancer Care Associates of York, York

19104

RECRUITING

University of Pennsylvania, Philadelphia

30310

RECRUITING

Morehouse, Atlanta

30318

RECRUITING

Piedmont Healthcare, Atlanta

30322

RECRUITING

Winship Cancer Institute, Emory University, Atlanta

37212

RECRUITING

Vanderbilt University, Nashville

43210

RECRUITING

Ohio State University, Columbus

45219

RECRUITING

University of Cincinnati, Cincinnati

48201

RECRUITING

Karmanos Cancer Institute, Detroit

54911

RECRUITING

ThedaCare, Appleton

60611

RECRUITING

Northwestern University Feinberg School of Medicine, Chicago

61615

RECRUITING

Illinois Cancer Care, Peoria

62526

RECRUITING

Cancer Care Specialists of Illinois, Decatur

63130

RECRUITING

Washington University in St. Louis, St Louis

65807

RECRUITING

Oncology Hematology Associates, Springfield

66205

RECRUITING

University of Kansas, Westwood

90033

RECRUITING

USC/Norris Comprehensive Cancer Center, Los Angeles

91010

RECRUITING

City of Hope, Duarte

94304

RECRUITING

Stanford, Palo Alto

95403

RECRUITING

Providence Medical Foundation, Santa Rosa

98109

RECRUITING

University of Washington, Seattle

00909

RECRUITING

Pan American Cancer for Oncology, San Juan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Tempus AI

INDUSTRY

NCT06163534 - A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) | Biotech Hunter | Biotech Hunter